Oral Rosiglitazone Supplementation Mitigates Pulmonary Cellular Stress Response During Lipopolysaccharide‐Evoked Acute Lung Injury in Mice
Canadian Respiratory Journal · 2026-01 · 2026 (1)
DOI: 10.1155/carj/1600008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Respiratory Journal, online erschienen am 05.08.2026. Verfasst von Jun-Ping Wei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Linquan County People's Hospital, Fuyang 236499, Anhui, China. Hauptthemen laut MEDLINE: Rosiglitazone, Acute Lung Injury, Oxidative Stress, Endoplasmic Reticulum Stress. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, University Natural Science Research Project of Anhui Province, Anhui Provincial Key Research and Development Plan.
Abstract (Originalsprache)
Cellular stress is implicated in the progression of lipopolysaccharide (LPS)‐evoked acute lung injury (ALI). The goal of this study was to evaluate the effect of oral supplementation with rosiglitazone (RSG), which is an agonist of peroxisome proliferator‐activated receptor (PPAR)‐γ, on pulmonary inflammatory response, oxidative stress, and endoplasmic reticulum (ER) stress during LPS‐evoked ALI in mice. The mice were randomly divided into four groups and orally supplemented with or without RSG (10 mg/kg) once daily for 5 consecutive days before LPS (1 mg/kg) intraperitoneal injection. The mice were sacrificed at 12 h after LPS injection. As expected, LPS‐evoked ALI and death were attenuated in mice that were pretreated with RSG. LPS‐evoked increase in chemokines (KC, MIP‐2, and MCP‐1) and proinflammatory cytokines (TNF‐α and IL‐1β) was inhibited in the mouse lungs by RSG. RSG pretreatment significantly mitigated LPS‐evoked nuclear translocation of NF‐κB p65 and p50, which regulate inflammatory gene transcription in the lungs. Additionally, LPS‐evoked glutathione depletion and lipid peroxidation were alleviated by RSG. The abnormal expression of NADPH oxidases and antioxidant enzymes was restored in the lung tissues by RSG. Further experiments revealed that LPS‐evoked upregulation of GRP78, p ‐IRE1α, and p ‐EIF2α was blocked by RSG pretreatment. Mechanistically, RSG pretreatment enhanced PPARγ activity in the mouse lungs and bronchial epithelial cells. RSG promoted the interaction between NF‐κB p65 and PPARγ in the mouse lungs. Overall, RSG pretreatment protects against LPS‐evoked ALI partially through enhancing PPARγ activity and inhibiting the cellular stress response in the mouse lungs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Linquan County People's Hospital, Fuyang 236499, Anhui, China.
- Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui, China, ahmu.edu.cn.
- Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui, China, ahmu.edu.cn.
ORCID-Profile: Jun-Ping Wei, Wei Cao, Zhao-Fei Liu, Zhen Liu, Zhen-Zhen Cao, Xiu Lu, Jia-Le Li, Min-Min Tang, Dong-Xu Hua, Lin Fu, Jun Fei, Ling Zheng
Förderung
- National Natural Science Foundation of China
- University Natural Science Research Project of Anhui Province
- Anhui Provincial Key Research and Development Plan
- Research Funds of Center for Big Data and Population Health of IHM
- Health Research Project of Fuyang City
Zitieren
APA
Wei, J. P., Cao, W., Liu, Z. F., Liu, Z., Cao, Z. Z., Lu, X., Li, J. L., Tang, M. M., Hua, D. X., Fu, L., Fei, J., & Zheng, L. (2026). Oral Rosiglitazone Supplementation Mitigates Pulmonary Cellular Stress Response During Lipopolysaccharide‐Evoked Acute Lung Injury in Mice. Canadian Respiratory Journal, 2026(1). https://doi.org/10.1155/carj/1600008
Vancouver
Wei JP, Cao W, Liu ZF, Liu Z, Cao ZZ, Lu X, et al. Oral Rosiglitazone Supplementation Mitigates Pulmonary Cellular Stress Response During Lipopolysaccharide‐Evoked Acute Lung Injury in Mice. Canadian Respiratory Journal. 2026;2026(1). doi:10.1155/carj/1600008
BibTeX
@article{Wei2026,
author = {Wei, Jun-Ping and Cao, Wei and Liu, Zhao-Fei and Liu, Zhen and Cao, Zhen-Zhen and Lu, Xiu and Li, Jia-Le and Tang, Min-Min and Hua, Dong-Xu and Fu, Lin and Fei, Jun and Zheng, Ling},
title = {Oral Rosiglitazone Supplementation Mitigates Pulmonary Cellular Stress Response During Lipopolysaccharide‐Evoked Acute Lung Injury in Mice},
journal = {Canadian Respiratory Journal},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/carj/1600008}
}
EUVIMED